Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

1998 • 19,638 citations

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

2002 • 10,002 citations

ECDEU Assessment Manual for Psychopharmacology

1976 • 8,729 citations

The McGill Pain Questionnaire: Major properties and scoring methods

1975 • 6,706 citations

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1997 • 6,073 citations

Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes

2003 • 4,328 citations

WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI: Ethical Principles for Medical Research Involving Human Subjects

2001 • 3,499 citations

World Medical Association Declaration of Helsinki

2000 • 2,287 citations

Ethical principles for medical research involving human subjects

2003 • 1,972 citations

Diabetic Neuropathies

2005 • 1,791 citations

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

1993 • 1,453 citations

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort

1993 • 1,410 citations

Vascular Risk Factors and Diabetic Neuropathy

2005 • 1,197 citations

Diabetic Somatic Neuropathies

2004 • 908 citations

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy

2001 • 674 citations

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study

1996 • 674 citations

Detection, characterization, and staging of polyneuropathy: Assessed in diabetics

1988 • 549 citations

Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.

1999 • 505 citations

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant ?-lipoic acid

1995 • 505 citations

Epidemiology of severe hypoglycemia in the diabetes control and complications trial

1991 • 465 citations

Risk Factors for Amputation in Patients with Diabetes Mellitus

1992 • 444 citations

[WHO Expert Committee on diabetes mellitus].

1981 • 422 citations

Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort

1997 • 376 citations

Walking stability and sensorimotor function in older people with diabetic peripheral neuropathy

2004 • 373 citations

Epidemiological Correlates of Diabetic Neuropathy: Report From Pittsburgh Epidemiology of Diabetes Complications Study

1989 • 358 citations

Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

1999 • 328 citations

Metabolic and Vascular Factors in the Pathogenesis of Diabetic Neuropathy

1997 • 314 citations

Modern Mathematical Statistics

1989 • 307 citations

Problems with Gait and Posture in Neuropathic Patients with Insulin‐Dependent Diabetes Mellitus

1992 • 298 citations

The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)

1998 • 296 citations

Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy

1989 • 286 citations

Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy

1988 • 280 citations

A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold

1993 • 280 citations

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy

1999 • 277 citations

Variables influencing neuropathic endpoints

1995 • 275 citations

Inhibition of Protein Kinase Cβ Prevents Impaired Endothelium-Dependent Vasodilation Caused by Hyperglycemia in Humans

2002 • 274 citations

Introduction of automated systems to evaluate touch‐pressure, vibration, and thermal cutaneous sensation in man

1978 • 204 citations

Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy

2005 • 178 citations

Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity

1995 • 161 citations

Quantitative measurement of cutaneous perception in diabetic neuropathy

1995 • 160 citations

Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy

1988 • 156 citations

A Multicenter Study on the Prevalence of Diabetic Neuropathy in Italy

1997 • 152 citations

Modern Mathematical Statistics.

1989 • 151 citations

SENSORY ACTION POTENTIALS AND BIOPSY OF THE SURAL NERVE IN NEUROPATHY

1978 • 143 citations

Diabetes, peripheral neuropathy, and old age disability

2001 • 138 citations

Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study.

2000 • 131 citations

Clinical Trials of Diabetic Neuropathy: Past, Present, and Future

1995 • 106 citations

A Comparison of Gait Characteristics Between Older Women with and Without Peripheral Neuropathy in Standard and Challenging Environments

2004 • 104 citations

Effects of the protein kinase Cβ inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes

2002 • 103 citations

Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials

2001 • 103 citations

Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study

1989 • 100 citations

Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

1988 • 95 citations

Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial

1996 • 92 citations

Diagnosis and Management of Diabetic Neuropathy

1999 • 81 citations

Vibratory Perception in Normal Subjects

1957 • 77 citations

Clinical utility of dorsal sural nerve conduction studies

2001 • 77 citations

Vibratory Perception in Diabetics

1957 • 73 citations

Impact of low frequency transcutaneous electrical nerve stimulation on symptomatic diabetic neuropathy using the new Salutaris device.

2004 • 68 citations

The role of protein kinase C in the development of the complications of diabetes

2000 • 67 citations

Possible role of the protein kinase C/CPI‐17 pathway in the augmented contraction of human myometrium after gestation

2003 • 67 citations

Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study

1998 • 66 citations

Sural nerve myelinated fiber density differences associated with meaningful changes in clinical and electrophysiologic measurements

1996 • 61 citations

Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months

1992 • 58 citations

New developments in the diagnosis of diabetic neuropathy

1999 • 58 citations

Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy

2005 • 58 citations

Clinical trials of diabetic neuropathy: past, present, and future

1995 • 46 citations

Electronic Case-Report Forms of Symptoms and Impairments of Peripheral Neuropathy

2002 • 45 citations

Progression Rates of Diabetic Neuropathy in Placebo Patients in an 18-Month Clinical Trial

1998 • 29 citations

The usefulness of minimal F-wave latency and sural/radial amplitude ratio in diabetic polyneuropathy

2000 • 26 citations

A Placebo‐controlled Double‐blind Study of Epalrestat (ONO‐2235) in Patients with Diabetic Neuropathy

1993 • 25 citations

Design of Controlled Clinical Trials for Diabetic Polyneuropathy

1996 • 23 citations

Prospects for Kinase Activity Modulators in the Treatment of Diabetes and Diabetic Complications

2002 • 23 citations

Distal sensory nerves of the lower extremity in peripheral neuropathy: comparison of medial dorsal cutaneous and sural nerve abnormalities.

1985 • 18 citations

Diabetic neuropathy: electrophysiologic abnormalities of distal lower extremity sensory nerves.

1986 • 16 citations

Cited By (0)

Loading...